Tyra Biosciences Inc
Biotechnology
Healthcare
TYRA
58.87 M shares
NASDAQ US
traded
09 Apr 2025
listed
no
open
7.06
52 week high
28.61
high
8.11
52 week low
7.06
low
6.42
growth
-51.17 %
previous Close
7.06
P/E ratio
market cap
713 M
div yield
0
usd
Sep 2024
qoq
revenue
0.00 %
net incoming
-24.02 M
-28.41 %
eps
0.00 %
-28.13 %
eps surprise
-4.59 %
net profit margin
-2401600000.00 %
0.00 %
operating incoming
-28.60 M
-21.55 %
net change in cash
4.40 M
102.84 %
cash on hand
104 M
4.42 %
cost of revenue
0.00 %
top top